Flaten Magne Arve
Department of Psychology, Norwegian University of Science and Technology, N-7491, Dragvoll, Trondheim, Norway,
Handb Exp Pharmacol. 2014;225:81-96. doi: 10.1007/978-3-662-44519-8_5.
Individuals undergoing treatment for a symptom like pain expect that the treatment will reduce the pain. Many studies show that healthy volunteers or patients in pain report less pain after inactive treatment, if they believe that active medication has been administrated. The reduction of pain can be partly blocked by systemic administration of naloxone, an opioid antagonist. There is reduced central nervous system activation to painful stimuli in individuals who have been given a placebo and told it is a painkiller. These findings suggest that the expectation of pain relief generates central nervous system opioid activity that inhibits pain transmission to the cerebral cortex. Expectations may thus lead to changes in central nervous system activity that reduces pain. It is proposed that expectations activate a homeostatic system that corrects perturbations to the system via negative feedback. The nocebo effect is the opposite of the placebo effect, and is due to induction of negative emotions. Part of the treatment of many symptoms and diseases is due to autonomic adjustments controlled by the central nervous system. The involvement of emotional processes in placebo effects could have important consequences for interpretation of data from randomized controlled trials.
正在接受疼痛等症状治疗的个体期望治疗能减轻疼痛。许多研究表明,健康志愿者或疼痛患者在接受无效治疗后,如果他们认为已服用了有效药物,会报告疼痛减轻。疼痛的减轻可部分被阿片类拮抗剂纳洛酮的全身给药所阻断。在服用安慰剂并被告知其为止痛药的个体中,对疼痛刺激的中枢神经系统激活有所减少。这些发现表明,对疼痛缓解的期望会产生中枢神经系统阿片类活性,从而抑制疼痛向大脑皮层的传递。因此,期望可能会导致中枢神经系统活动的变化,进而减轻疼痛。有人提出,期望会激活一个稳态系统,该系统通过负反馈纠正对系统的干扰。反安慰剂效应与安慰剂效应相反,是由负面情绪的诱导引起的。许多症状和疾病的部分治疗归因于中枢神经系统控制的自主调节。情绪过程在安慰剂效应中的参与可能会对随机对照试验的数据解释产生重要影响。